Tariff Roulette: Trump’s Tariff Gambit Keeps Risk On A Hair Trigger For now, the market remains in limbo - positioning on edge, risk bids cautious, and volatility waiting in the wings.
Should You Buy NMAX? History Says Wait NMAX exploded 700% on its IPO day, but history tells a different story.
Why The FTSE Flies In April The FTSE 100 has one of the strongest April patterns among global indices.
Can March Swing Lows Hold? The Nasdaq has registered two higher volume distribution days in the past four with the MACD clinging on to its earlier 'buy' trigger.
Tuesday's after hours session: top gainers and losers Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Rivian CEO Says US Needs More Under $50K EVs To Catch Up To China: 'You Have To Have The Plumbing Right' The highly anticipated R2 from Rivian could be a catalyst for the stock. The vehicle could also help the U.S. EV market catch up to China. Here's why.
Which Of These Defense Stocks Is A Good Offense For Your Portfolio? Analysis of two aerospace and defense stocks – Huntington Ingalls Industries and Lockheed Martin.
The Top 3 Stocks In March Much has been written about why things have turned south for stocks this year, but March was particularly brutal as markets braced for new tariffs and the threat of recession.
EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank? A look at the top 20 most-searched stocks on Benzinga Pro in March. While many had news in the month that could affect rankings, the trends could be a sign of what's to come.
Taiwan Semiconductor Is Down 15% Year-To-Date And Investors Are Concerned About Its Expansion Plans Taiwan Semiconductor's stock value dropped 18% during Trump's presidency, due to concerns about its US expansion and potential monopoly issues.
Heavy Truck Sales Warrant A Yellow Caution Flag Heavy truck sales were 438,000 annualized, the lowest monthly number since January 2022.
3 Value Stocks Worth Buying In Current Market Conditions Big Pharma, Big Tech and REIT is on the value menu. Discount opportunities at this level are rare.
